Literature DB >> 28105556

Chikungunya infection presenting as mild encephalitis with a reversible lesion in the splenium: a case report.

Kadam Nagpal1, Puneet Agarwal2, Amit Kumar3, Rajashekhar Reddi2.   

Abstract

Chikungunya fever is an Aedes mosquito-transmitted infection caused by chikungunya virus, an RNA virus in the family Togaviridae. The disease is characteristically manifested as fever, arthralgia, and/or rash. Various neurological manifestations like meningoencephalitis, myelitis, and myeloneuropathy have been mentioned in various reports. We present a rare case of chikungunya fever presenting with mild encephalitis with a reversible lesion of the splenium (MERS), which showed complete clinical and radiological recovery.

Entities:  

Keywords:  Chikungunya; Encephalitis; Reversible splenial lesion

Mesh:

Substances:

Year:  2017        PMID: 28105556     DOI: 10.1007/s13365-017-0515-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   3.739


  13 in total

1.  An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features.

Authors:  M C ROBINSON
Journal:  Trans R Soc Trop Med Hyg       Date:  1955-01       Impact factor: 2.184

Review 2.  The corpus callosum: white matter or terra incognita.

Authors:  A Fitsiori; D Nguyen; A Karentzos; J Delavelle; M I Vargas
Journal:  Br J Radiol       Date:  2011-01       Impact factor: 3.039

3.  Reversible splenial lesion in clinically mild encephalitis.

Authors:  I B Yeh; L C S Tan; Y Y Sitoh
Journal:  Singapore Med J       Date:  2005-12       Impact factor: 1.858

4.  Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study.

Authors:  R J Condon; I L Rouse
Journal:  Clin Diagn Virol       Date:  1995-03

Review 5.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion.

Authors:  H Tada; J Takanashi; A J Barkovich; H Oba; M Maeda; H Tsukahara; M Suzuki; T Yamamoto; T Shimono; T Ichiyama; T Taoka; O Sohma; H Yoshikawa; Y Kohno
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Widening spectrum of a reversible splenial lesion with transiently reduced diffusion.

Authors:  J Takanashi; A J Barkovich; T Shiihara; H Tada; M Kawatani; H Tsukahara; M Kikuchi; M Maeda
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

7.  Neurological complications in Chikungunya fever.

Authors:  Meenaxi Sharda; H Meena
Journal:  J Assoc Physicians India       Date:  2007-11

Review 8.  Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.

Authors:  M Conti; A Salis; C Urigo; L Canalis; S Frau; G C Canalis
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

9.  Neurological complications of Chikungunya virus infection.

Authors:  Nitin H Chandak; Rajpal S Kashyap; Dinesh Kabra; Poornima Karandikar; Sonali S Saha; Shweta H Morey; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  Neurol India       Date:  2009 Mar-Apr       Impact factor: 2.117

10.  Mild encephalopathy with reversible lesion in the splenium of the corpus callosum and bilateral frontal white matter.

Authors:  Jeong-Seon Cho; Sang-Won Ha; Young-Su Han; Sang-Eun Park; Ki-Moo Hong; Jeong-Ho Han; Eun-Kyoung Cho; Doo-Eung Kim; Jea-Geun Kim
Journal:  J Clin Neurol       Date:  2007-03-20       Impact factor: 3.077

View more
  2 in total

Review 1.  The neurological complications of chikungunya virus: A systematic review.

Authors:  Ravi Mehta; Patrick Gerardin; Carlos Alexandre Antunes de Brito; Cristiane Nascimento Soares; Maria Lucia Brito Ferreira; Tom Solomon
Journal:  Rev Med Virol       Date:  2018-04-19       Impact factor: 6.989

Review 2.  Mild encephalitis/encephalopathy with a reversible splenial lesion secondary to encephalitis complicated by hyponatremia: A case report and literature review.

Authors:  Bi-Chuan Shi; Jiao Li; Ji-Wei Jiang; Mei-Xin Li; Jian Zhang; Xiu-Li Shang
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.